anticoagulant sales likely to double over next decade

1
Inpharma 1657 - 27 Sep 2008 Anticoagulant sales for STEMI (ST-elevation myocardial infarction) are likely to double over the next decade, according to a report by Decision Resources. Sales are predicted to increase from $US56.7 million in 2007 to over $US114 million by 2017, largely due to the availability of newer anticoagulants with superior efficacy to unfractionated heparin for STEMI treatment. Specifically, the patient share of bivalirudin [Angiomax, Angiox] is expected to grow by about 16%, and fondaparinux sodium [Arixtra] by at least 9%, in France, Germany, Italy, Japan, Spain, the UK and the US. Decision Resources. Sales of Anticoagulants for the Treatment of St-Elevation Myocardial Infarction Will Double Over the Next 10 Years. Media Release : 22 Sep 2008. Available from: URL: http:// www.decisionresources.com 809093342 1 Inpharma 27 Sep 2008 No. 1657 1173-8324/10/1657-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Post on 08-Dec-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Anticoagulant sales likely to double over next decade

Inpharma 1657 - 27 Sep 2008

■ Anticoagulant sales for STEMI (ST-elevationmyocardial infarction) are likely to double over thenext decade, according to a report by DecisionResources. Sales are predicted to increase from$US56.7 million in 2007 to over $US114 million by2017, largely due to the availability of neweranticoagulants with superior efficacy to unfractionatedheparin for STEMI treatment. Specifically, the patientshare of bivalirudin [Angiomax, Angiox] is expected togrow by about 16%, and fondaparinux sodium [Arixtra]by at least 9%, in France, Germany, Italy, Japan, Spain,the UK and the US.Decision Resources. Sales of Anticoagulants for the Treatment of St-ElevationMyocardial Infarction Will Double Over the Next 10 Years. Media Release :22 Sep 2008. Available from: URL: http://www.decisionresources.com 809093342

1

Inpharma 27 Sep 2008 No. 16571173-8324/10/1657-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved